GlycoMimetics News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
GlycoMimetics Inc GLYC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.05 1.39% 3.66 15:00:02
Open Price Low Price High Price Close Price Previous Close
3.59 3.5058 3.68 3.66 3.61
more quote information »

Recent News

Date Time Source Heading
11/10/202016:00BWGlycoMimetics to Present at Two Upcoming Virtual Healthcare..
11/06/202018:34EDGARStatement of Changes in Beneficial Ownership (4)
11/06/202009:30EDGARCurrent Report Filing (8-k)
11/06/202007:30BWGlycoMimetics Reports Highlights and Financial Results for..
11/04/202013:03BWGlycoMimetics Program Data to be Highlighted Via Three Oral..
10/30/202009:00BWGlycoMimetics to Report Third Quarter Financial Results on..
10/26/202009:00BWNew Pediatric & Secondary Endpoint Data from Rivipansel..
10/07/202016:58EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
10/07/202016:16EDGARCurrent Report Filing (8-k)
10/05/202016:30BWFDA Grants GlycoMimetics Rare Pediatric Disease Designation..
9/08/202016:00BWGlycoMimetics to Present at Upcoming H.C. Wainwright & Co..
9/04/202009:00BWGlycoMimetics Reports Inducement Grants Under NASDAQ Listing..
8/31/202009:00BWNew Preclinical GlycoMimetics Data Suggests Uproleselan With..
7/31/202009:10EDGARCurrent Report Filing (8-k)
7/31/202009:01EDGARQuarterly Report (10-q)
7/31/202008:00BWGlycoMimetics Reports Highlights and Financial Results for..
7/24/202009:15BWGlycoMimetics to Report Second Quarter Financial Results on..
7/20/202016:35EDGARStatement of Ownership (sc 13g)
7/10/202015:19EDGARSchedule 13g
7/10/202009:00BWGlycoMimetics Reports Inducement Grant Under NASDAQ Listing..
6/12/202012:23BWNew Efficacy and Biomarker Data From Rivipansel Phase 3..
5/29/202009:00BWGlycoMimetics to Present at Upcoming Jefferies Virtual..
5/27/202016:34EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202016:33EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202016:31EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202016:30EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202016:29EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202016:27EDGARStatement of Changes in Beneficial Ownership (4)
5/26/202016:31EDGARCurrent Report Filing (8-k)
5/15/202012:30BWGlycoMimetics to Present New Preclinical Data Highlighting..
5/08/202009:00EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/08/202008:30BWGlycoMimetics Announces Change to Virtual Meeting Format for..
5/01/202009:01EDGARCurrent Report Filing (8-k)
5/01/202008:32EDGARQuarterly Report (10-q)
5/01/202007:00BWGlycoMimetics Reports Operational Highlights and Financial..
4/30/202009:00BWCompelling Data on Mechanism of Action for GlycoMimetics’..
4/24/202009:00BWGlycoMimetics to Report First Quarter Financial Results on..
4/16/202008:31EDGARProxy Statement (definitive) (def 14a)
4/09/202013:14EDGARSchedule 13g
4/09/202008:53EDGARSchedule 13g
4/07/202009:15BWGlycoMimetics Appoints Dr. Myra Rosario Herrle as Vice..
4/06/202016:15BWGlycoMimetics Reports Inducement Grant Under NASDAQ Listing..
3/10/202018:13EDGARStatement of Changes in Beneficial Ownership (4)
2/28/202016:04EDGARSecurities Registration: Employee Benefit Plan (s-8)
2/28/202011:01EDGARCurrent Report Filing (8-k)
2/28/202008:32EDGARAnnual Report (10-k)
2/28/202008:07BWGlycoMimetics Reports Highlights and Financial Results for..
2/25/202009:00BWGlycoMimetics to Present at the Cowen and Company 40th..
2/14/202015:13EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202013:39EDGARAmended Statement of Ownership (sc 13g/a)
See more news about this stock »

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.